chr6-88141462-T-C

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -12 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_Strong

The NM_016083.6(CNR1):c.*2394A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.105 (AC=15,960) in the gnomAD database across 152,484 control chromosomes, including 991 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.166. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.10 ( 988 hom., cov: 32)
Exomes 𝑓: 0.12 ( 3 hom. )

Consequence

CNR1
NM_016083.6 3_prime_UTR

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.76

Publications

76 publications found
Variant links:
Genes affected
CNR1 (HGNC:2159): (cannabinoid receptor 1) This gene encodes one of two cannabinoid receptors. The cannabinoids, principally delta-9-tetrahydrocannabinol and synthetic analogs, are psychoactive ingredients of marijuana. The cannabinoid receptors are members of the guanine-nucleotide-binding protein (G-protein) coupled receptor family, which inhibit adenylate cyclase activity in a dose-dependent, stereoselective and pertussis toxin-sensitive manner. The two receptors have been found to be involved in the cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana. Multiple transcript variants encoding two different protein isoforms have been described for this gene. [provided by RefSeq, May 2009]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_016083.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Benign. The variant received -12 points.

BP4Computational evidence suggests no impact
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Strong).
BA1Stand-alone benign allele frequency (>5%)
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.1662 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_016083.6. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

CNR1 NM_016083.6
MANE Select
HGVSc / HGVSpc.*2394A>G
Exon rankExon 2 of 2
3_prime_UTR
Prot: NP_057167.2
CNR1 NM_001160226.3
HGVSc / HGVSpc.*2394A>G
Exon rankExon 3 of 3
3_prime_UTR
Prot: NP_001153698.1UniProt: P21554-1
CNR1 NM_001160258.3
HGVSc / HGVSpc.*2394A>G
Exon rankExon 4 of 4
3_prime_UTR
Prot: NP_001153730.1UniProt: P21554-1

Ensembl Transcripts

CNR1 ENST00000369501.3
TSL:1MANE Select
HGVSc / HGVSpc.*2394A>G
Exon rankExon 2 of 2
3_prime_UTR
Prot: ENSP00000358513.2UniProt: P21554-1
CNR1 ENST00000428600.3
TSL:1
HGVSc / HGVSpc.*2394A>G
Exon rankExon 2 of 2
3_prime_UTR
Prot: ENSP00000412192.2UniProt: P21554-1
CNR1 ENST00000468898.2
TSL:1
HGVSc / HGVSpc.*2394A>G
Exon rankExon 2 of 2
3_prime_UTR
Prot: ENSP00000420188.1UniProt: P21554-3

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 5 sources
GnomAD3 genomes
AF: 0.104
AC:15900
Hom:983
AN:152154
Cov:32
GnomAD4 exome
AF: 0.118
AC:25
Hom:3
AN:212
Cov:0
GnomAD4 genome
AF: 0.105
AC:15935
Hom:988
AN:152272
Cov:32
TOPMed (Bravo)
AF: 0.108
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.108
AC:8138
Hom:474
AN:75448
Local & regional cohorts 10 sources
ABraOM SABE-WGS-1171
AF: 0.109
AC:255
Hom:8
AN:2342
ChinaMAP Phase 1
AF: 0.00478
Denmark Genome
AF: 0.0967
AC:29
AN:300
GenomeAsia100K
AF: 0.0460
AC:159
AN:3478
Korea4K (4,157 Koreans)
AF: 0.00525
AC:38
AN:7234
Qatari Genome
AF: 0.0739
AC:13
AN:176
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.00206
AC:253
Hom:2
AN:122774
Turkish Variome
AF: 0.0705
AC:109
Hom:1
AN:1546
UK10K
AF: 0.0899
AC:680
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.00413
AC:37
Hom:0
AN:8960
Showing 15 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
SCHEMA
(Schizophrenia)
0.0627 142422726 0.0284 82929190
Showing 1 cohortAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Uncertain13
BayesDel_noAF
Benign-0.71
CADD
Benign7.6
DANN
Benign0.74
GPN-Star LLR
N/A-3.0
GPN-Star score
N/A3.0
Mutation Taster
N/A100/0polymorphism (auto)
PhyloP100
Benign1.8
Showing 8 of 8 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.